Vanguard Group Inc Celcuity Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,672,242 shares of CELC stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,672,242

Previous 1,651,981 1.23%

Holding current value

$17.8 Million

Previous $21.6 Million 21.82%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$8.62 - $13.62 $174,649 - $275,954	20,261 Added 1.23%	1,672,242 $16.9 Million
Q4 2024 Feb 11, 2025	BUY	$12.0 - $16.35 $293,148 - $399,414	24,429 Added 1.5%	1,651,981 $21.6 Million
Q3 2024 Nov 13, 2024	BUY	$13.98 - $19.15 $866,242 - $1.19 Million	61,963 Added 3.96%	1,627,552 $24.3 Million
Q2 2024 Aug 13, 2024	BUY	$14.1 - $20.78 $10.4 Million - $15.3 Million	736,992 Added 88.94%	1,565,589 $25.6 Million
Q1 2024 May 10, 2024	BUY	$13.74 - $21.6 $107,460 - $168,933	7,821 Added 0.95%	828,597 $17.9 Million
Q4 2023 Feb 14, 2024	BUY	$8.7 - $15.02 $253,874 - $438,298	29,181 Added 3.69%	820,776 $12 Million
Q3 2023 Nov 14, 2023	BUY	$8.96 - $10.75 $83,910 - $100,673	9,365 Added 1.2%	791,595 $7.24 Million
Q2 2023 Aug 14, 2023	BUY	$9.39 - $12.18 $641,506 - $832,113	68,318 Added 9.57%	782,230 $8.59 Million
Q1 2023 May 15, 2023	BUY	$9.4 - $12.82 $2.66 Million - $3.63 Million	283,424 Added 65.84%	713,912 $7.32 Million
Q4 2022 Feb 10, 2023	SELL	$7.55 - $14.01 $89,520 - $166,116	-11,857 Reduced 2.68%	430,488 $6.03 Million
Q3 2022 Nov 14, 2022	SELL	$8.0 - $10.64 $8,000 - $10,640	-1,000 Reduced 0.23%	442,345 $4.44 Million
Q2 2022 Aug 12, 2022	SELL	$5.35 - $10.11 $262,101 - $495,299	-48,991 Reduced 9.95%	443,345 $4.03 Million
Q1 2022 May 13, 2022	SELL	$7.93 - $13.33 $872 - $1,466	-110 Reduced 0.02%	492,336 $4.6 Million
Q4 2021 Feb 14, 2022	SELL	$11.96 - $19.35 $3,887 - $6,288	-325 Reduced 0.07%	492,446 $6.5 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $24.87 $993,148 - $1.42 Million	57,242 Added 13.14%	492,771 $8.87 Million
Q2 2021 Aug 13, 2021	BUY	$14.25 - $30.93 $6.21 Million - $13.5 Million	435,529 New	435,529 $10.5 Million

Others Institutions Holding CELC

# of Institutions

Shares Held

30.6M

Call Options Held

16.2K

Put Options Held

51.9K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $159M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Celcuity Inc. Transaction History